FY2025 EPS Estimate for Beam Therapeutics Lifted by Analyst
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Cantor Fitzgerald raised their FY2025 earnings per share estimates for shares of Beam Therapeutics in a research report issued on Wednesday, March 12th. Cantor Fitzgerald analyst R. Bienkowski now expects that the company will earn ($3.27) per share for the year, up from their […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Cantor Fitzgerald raised their FY2025 earnings per share estimates for shares of Beam Therapeutics in a research report issued on Wednesday, March 12th. Cantor Fitzgerald analyst R. Bienkowski now expects that the company will earn ($3.27) per share for the year, up from their […]
